Yayınlanmış 1 Ocak 2018
| Sürüm v1
Dergi makalesi
Açık
EurA1c: The European HbA1c Trial to Investigate the Performance of HbA1c Assays in 2166 Laboratories across 17 Countries and 24 Manufacturers by Use of the IFCC Model for Quality Targets
Oluşturanlar
- Weykamp, Cas1
- John, W. Garry2
- English, Emma3
- Erasmus, Rajiv T.4
- Sacks, David B.5
- Buchta, Christoph6
- Mueller, Mathias M.6
- Lenga, Yolande7
- Budina, Marek8
- Kratochvila, Josef8
- Friedecky, Bedrich8
- Siest, Jean-Pascal9
- Kaiser, Patricia10
- Haliassos, Alexander11
- Panagiotakis, Otto11
- Makris, Konstantinos11
- Graham, Hazel12
- Kane, Anne12
- Smith, Thomas P.12
- Barrett, Ned12
- Barrett, Ned12
- 1. Queen Beatrix Hosp, Winterswijk, Netherlands
- 2. Norfolk & Norwich Univ Hosp, Norwich, Norfolk, England
- 3. Univ East Anglia, Norwich, Norfolk, England
- 4. Tygerberg Hosp, Tygerberg, South Africa
- 5. NIH, Washington, DC USA
- 6. OQUASTA, Vienna, Austria
- 7. WIV ISP, Brussels, Belgium
- 8. SEKK, Pardubice, Czech Republic
- 9. Biol Prospect, Villers Les Nancy, France
- 10. INSTAND, Dusseldorf, Germany
- 11. ESEAP Gen Hosp, Athens, Greece
- 12. IEQAS, Dublin, Ireland
Açıklama
BACKGROUND: A major objective of the IFCC Committee on Education and Use of Biomarkers in Diabetes is to generate awareness and improvement of HbA1c assays through evaluation of the performance by countries and manufacturers.
Dosyalar
bib-b1d67b2b-5fc5-4b79-95bc-8e110a2e866c.txt
Dosyalar
(488 Bytes)
| Ad | Boyut | Hepisini indir |
|---|---|---|
|
md5:859c142ec3963aa021a2618faf4ef3ac
|
488 Bytes | Ön İzleme İndir |